Tweed Marijuana Stocks 3rd Most Traded in Canada, Up 183% in Friday Trading
By Vittorio Hernandez | April 8, 2014 9:25 AM EST
It is not just the Wolf of Weed Street who made a lot of money on trading medical cannabis stocks. Early traders of Tweed Marijuana (TWD) shares on Friday, when the company became the first publicly traded producer of medical weed at the TSX Venture Exchange in Canada, also got a financial high.
Marijuana plants are seen in an indoor cultivation in Montevideo December 6, 2013.
That day, shares of Tweed soared 183 per cent at 2:07 pm from its issued price on March 7 of 89 cents to $2.52. It had actually gone down from the opening price of $5.10 but is still the third-most traded issued in Canada as 9.64 million shares were either sold or bought.
Over the weekend, the Smith Falls, Ontario-based company disclosed that it purchased over 60 new strains of medical marijuana seeds and plants from licensed growers. The firm's current market value is $89 million.
Tweed will sell 25 strains to Canadian patients for $5-$12 per gramme, shipping included. Minimum order is 1 gramme, and delivery is via bonded courier.
Health Canada estimates that within the next decade, the medical pot market could grow to $1.3 billion.
In the U.S., medical marijuana shares have ballooned at even higher rates. For 2014, shares of Tranzbyte Corp, which sells cannabis in Colorado following the drug's legalisation, soared 2,352 per cent. Another firm, GreenGro Technologies, provider of management services to medical marijuana dispensaries, enjoyed an 892 per cent boost in its share prices since January.
However, Metro Canada columnist Alison Griffiths warned against placing too much faith in marijuana shares since the cannabis industry is "too young to qualify as a sound investment or even a reasonable speculation."
She cited that some stocks such as that of Advanced Cannabis Solutions (CANN), Hemp Inc (HEMP) and GrowLife (PHOT) are mostly traded informally over-the-counter exchanges or bulletin boards, making its trading volume data dubious if not erratic.
The Securities and Exchange Commission has actually suspended trading in CANN stock due to suspicions of insider trading.
Likewise, InvestorPlace writer Dan Burrows urged readers to run away from the four largest marijuana stocks "without looking back," namely CannaVest (CANV), Medical Marijuana (MJNA), GrowLife and Cannabis Science (CBIS).
He pointed out that besides not being traded in major exchanges like the New York Stock Exchange of Nasdaq, they are not the types of bourse guidelines to help validate an enterprise and provide transparency.
Besides Tweed, other Canadian medical cannabis publicly listed firms are also enjoying some amount of success. It includes Maple Leaf Green World (V.MGW) whose stocks are up 1,750 per cent since mid-March and Chlormet Technology (V.CMT) which logged a 50.8 per cent growth in share price on Thursday.
To contact the editor, e-mail:
Most Popular Slideshows
- Taylor Swift Named Forbes' Second Highest Paid Country Musician [PHOTOS]
- Lunch with the Gods: Pope Francis Eats with Vatican Workers in Cafeteria
Join the Conversation
- El Pollo Loco Shareprice Up 33% on 1st Day of Trading
- South Australia OKs $800M Copper, Gold & Iron Ore Mine on Prime Agri Land in Yorke Peninsula
- Australian Stock Market Report –Midday July 30, 2014
- Long Beach Real Estate Market Is Pricing Out Home Buyers with Limited Budget
- Shanghai Stock Exchange Will Not Extend Trading Hours
- Childhood Obesity is Strongly Linked With Early Puberty: Study Reveals
- Why Internet of Things is the Next Big Thing for Tech Giants like Samsung, Google and Apple
- Instagram's Newest App Bolt Now Available Exclusively in New Zealand, Singapore and South Africa
- Megan Fox's Weight Loss Aided by Low Carb Paleo Diet: Benefits of the Diet